UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Catalogue
Articles
RSS feedX
Search Filters
Format
Subjects
Library Location
Language
Publication DateThe Journal of infectious diseases, ISSN 0022-1899, 11/2014, Volume 210, Issue 9, pp. 1357 - 1366
Biofilms | Antibiotics | Escherichia coli | Bacteria | Aminoglycosides | Pseudomonas aeruginosa | Infections | Basic amino acids | Staphylococcus aureus | aminoglycoside | persister | catheter-related infections | biofilm | proton motive force | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Escherichia coli Infections - prevention & control | Central Venous Catheters - microbiology | Escherichia coli - drug effects | Gentamicins - administration & dosage | Catheter-Related Infections - prevention & control | Pseudomonas Infections - prevention & control | Arginine - administration & dosage | Gentamicins - pharmacology | Drug Therapy, Combination | Biofilms - drug effects | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Pseudomonas Infections - drug therapy | Rats | Central Venous Catheters - adverse effects | Pseudomonas aeruginosa - drug effects | Catheter-Related Infections - drug therapy | Drug Synergism | Animals | Arginine - pharmacology | Staphylococcal Infections - prevention & control | Anti-Bacterial Agents - pharmacology | In Vitro Techniques | Staphylococcus aureus - drug effects | Hydrogen-Ion Concentration | Health aspects | Research | Index Medicus | Abridged Index Medicus | Biofilms/drug effects | Gentamicins/administration & dosage | Anti-Bacterial Agents/pharmacology | Staphylococcal Infections/drug therapy | Arginine/administration & dosage | Life Sciences | Escherichia coli Infections/drug therapy | Staphylococcus aureus/drug effects | Gentamicins/pharmacology | Catheter-Related Infections/prevention & control | Pseudomonas aeruginosa/drug effects | Staphylococcal Infections/prevention & control | Catheter-Related Infections/drug therapy | Central Venous Catheters/microbiology | Escherichia coli/drug effects | Bacteriology | Microbiology and Parasitology | Central Venous Catheters/adverse effects | Arginine/pharmacology | Pseudomonas Infections/prevention & control | Escherichia coli Infections/prevention & control | Pseudomonas Infections/drug therapy
Journal Article
Details 
Digital rights
Loading RightsBurns, ISSN 0305-4179, 2016, Volume 43, Issue 3, pp. 642 - 653
Critical Care | Nosocomial infection | Burn wound infection | Pneumonia | Urinary tract infection | Health care related infection | Burns | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Dermatology | Surgery | Science & Technology | Escherichia coli | Humans | Middle Aged | Child, Preschool | Male | Young Adult | Folliculitis - epidemiology | Aged, 80 and over | Urinary Tract Infections - microbiology | Catheter-Related Infections - epidemiology | Child | Infant, Newborn | Staphylococcus aureus | Escherichia coli Infections - drug therapy | Bacteremia - drug therapy | Pseudomonas Infections - microbiology | Wound Infection - epidemiology | Catheter-Related Infections - drug therapy | Drug Resistance, Microbial | Escherichia coli Infections - epidemiology | Acinetobacter baumannii | Catheter-Related Infections - microbiology | Adolescent | Bacteremia - epidemiology | Infant | Bacteremia - microbiology | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Adult | Female | Pseudomonas aeruginosa | Staphylococcal Infections - microbiology | Wound Infection - drug therapy | Acinetobacter Infections - microbiology | Staphylococcal Infections - drug therapy | Colombia - epidemiology | Klebsiella Infections - drug therapy | Central Venous Catheters | Pneumonia - epidemiology | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Folliculitis - microbiology | Pneumonia - microbiology | Klebsiella Infections - microbiology | Oxacillin - therapeutic use | Burns - epidemiology | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Pneumonia - drug therapy | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Wound Infection - microbiology | Aged | Folliculitis - drug therapy | Klebsiella pneumoniae | Development and progression | Burns and scalds | Surgery, Plastic | Health aspects | Staphylococcus aureus infections | Analysis | Bacterial pneumonia | Mortality | Urinary tract infections | Bacteria | Disease susceptibility | Antibacterial agents | Index Medicus
Journal Article
Details
Digital rights
Loading RightsAmerican journal of respiratory and critical care medicine, ISSN 1073-449X, 10/2019, Volume 200, Issue 7, pp. E45 - E67
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Community-Acquired Infections - diagnosis | Culture Techniques | United States | Humans | Pneumonia, Pneumococcal - diagnosis | Haemophilus Infections - diagnosis | Anti-Bacterial Agents - therapeutic use | Community-Acquired Infections - drug therapy | Adult | Haemophilus Infections - metabolism | Drug Therapy, Combination | Haemophilus Infections - drug therapy | Pneumonia, Mycoplasma - metabolism | Severity of Illness Index | Chlamydophila Infections - drug therapy | Blood Culture | Chlamydophila Infections - metabolism | Legionellosis - diagnosis | Hospitalization | Legionellosis - drug therapy | Pneumonia, Bacterial - diagnosis | Ambulatory Care | Moraxellaceae Infections - drug therapy | Chlamydophila Infections - diagnosis | Pneumonia, Pneumococcal - metabolism | Antigens, Bacterial - urine | Pneumonia, Staphylococcal - drug therapy | Moraxellaceae Infections - metabolism | Pneumonia, Staphylococcal - diagnosis | Pneumonia, Staphylococcal - metabolism | Sputum | Pneumonia, Bacterial - drug therapy | Legionellosis - metabolism | Pneumonia, Pneumococcal - drug therapy | Radiography, Thoracic | Moraxellaceae Infections - diagnosis | Macrolides - therapeutic use | beta-Lactams - therapeutic use | Pneumonia, Mycoplasma - diagnosis | Pneumonia, Mycoplasma - drug therapy | Clinical trials | Pneumonia | Adults | Medical diagnosis | Medical treatment | Index Medicus | Abridged Index Medicus | community-acquired pneumonia | American Thoracic Society Documents | pneumonia; patient management
Journal Article
Details
Digital rights
Loading RightsAmerican journal of respiratory and critical care medicine, ISSN 1073-449X, 03/2016, Volume 193, Issue 5, pp. 504 - 515
Healthy controls | Cystic fibrosis | Microbiota | Nasopharynx | Longitudinal | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Carrier State - epidemiology | Streptococcus mitis - genetics | Prospective Studies | Humans | Corynebacterium Infections - epidemiology | Carrier State - microbiology | Haemophilus Infections - epidemiology | Infant | Male | Corynebacterium Infections - microbiology | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Enterobacteriaceae Infections - epidemiology | Female | Staphylococcal Infections - microbiology | Nasopharynx - microbiology | Real-Time Polymerase Chain Reaction | Burkholderia Infections - microbiology | Haemophilus Infections - drug therapy | Infant, Newborn | Staphylococcus aureus - genetics | Moraxellaceae Infections - epidemiology | Streptococcal Infections - microbiology | Burkholderia - genetics | Staphylococcal Infections - drug therapy | Burkholderia Infections - epidemiology | Cystic Fibrosis - microbiology | Enterobacteriaceae Infections - microbiology | Enterobacteriaceae - genetics | Moraxellaceae Infections - microbiology | Streptococcal Infections - epidemiology | Haemophilus influenzae - genetics | Corynebacterium - genetics | Cystic Fibrosis - epidemiology | Moraxellaceae Infections - drug therapy | DNA, Bacterial - genetics | Staphylococcal Infections - epidemiology | Corynebacterium Infections - drug therapy | Microbiota - genetics | Burkholderia Infections - drug therapy | Haemophilus Infections - microbiology | RNA, Ribosomal, 16S - genetics | Streptococcal Infections - drug therapy | Moraxella - genetics | Cohort Studies | Enterobacteriaceae Infections - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details
Digital rights
Loading RightsEuropean journal of clinical microbiology & infectious diseases, ISSN 0934-9723, 9/2018, Volume 37, Issue 9, pp. 1627 - 1636
Medical Microbiology | Biomedicine | Targeted therapy | Escherichia coli | Bloodstream infections | Internal Medicine | ESKAPE | Antimicrobial resistance | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Escherichia coli - drug effects | Humans | Escherichia coli Infections - blood | Molecular Targeted Therapy | Incidence | Bacteremia - microbiology | Hospitals, Teaching - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Drug Resistance, Multiple, Bacterial | Staphylococcal Infections - microbiology | Catheter-Related Infections - epidemiology | Cross Infection - epidemiology | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Bacteremia - drug therapy | Escherichia coli Infections - microbiology | beta-Lactamases - drug effects | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cross Infection - drug therapy | Catheter-Related Infections - drug therapy | Bacterial Proteins - drug effects | Escherichia coli Infections - epidemiology | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Catheter-Related Infections - microbiology | Cross Infection - microbiology | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Drug resistance in microorganisms | Pneumonia | Bacterial pneumonia | Beta lactamases | Health aspects | Public health | Klebsiella | Health care | Pathogens | Communities | Carbapenemase | Antimicrobial agents | Infections | Drug resistance | Antiinfectives and antibacterials | Methicillin | E coli | Pseudomonas aeruginosa | Bacteria | Meropenem | Trends | Ciprofloxacin | Active control | Emergency medical services | Ceftazidime | Index Medicus
Journal Article
Details
Digital rights
Loading RightsAmerican journal of respiratory and critical care medicine, ISSN 1073-449X, 2001, Volume 163, Issue 6, pp. 1371 - 1375
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Antibacterial agents | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Recurrence | Enterobacteriaceae Infections - diagnosis | Prospective Studies | Humans | Middle Aged | Haemophilus Infections - blood | Male | Pneumococcal Infections - diagnosis | Haemophilus Infections - diagnosis | Pseudomonas Infections - blood | Respiration, Artificial - adverse effects | Time Factors | Pneumonia - diagnosis | Pneumonia - blood | Pneumococcal Infections - etiology | Risk Factors | Enterobacteriaceae Infections - etiology | Pseudomonas Infections - diagnosis | Cross Infection - drug therapy | Pneumococcal Infections - blood | Cross Infection - diagnosis | Bacterial Infections - blood | Cross Infection - blood | Enterobacteriaceae Infections - drug therapy | Practice Guidelines as Topic | Staphylococcal Infections - etiology | Pneumococcal Infections - drug therapy | Pseudomonas Infections - etiology | Cross Infection - etiology | Bacterial Infections - etiology | Infection Control - methods | Haemophilus influenzae | Bronchoalveolar Lavage Fluid - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Adult | Female | Leukocyte Count | Haemophilus Infections - drug therapy | Staphylococcal Infections - blood | Staphylococcal Infections - drug therapy | Pneumonia - etiology | Pseudomonas Infections - drug therapy | Proportional Hazards Models | Treatment Outcome | Haemophilus Infections - etiology | Staphylococcal Infections - diagnosis | Pneumonia - drug therapy | Enterobacteriaceae Infections - blood | Aged | Bacterial Infections - diagnosis | Drug Monitoring | Index Medicus | Abridged Index Medicus
Journal Article
Details
Digital rights
Loading RightsClinical orthopaedics and related research, ISSN 0009-921X, 7/2013, Volume 471, Issue 7, pp. 2383 - 2399
Surgical Orthopedics | Medicine & Public Health | Sports Medicine | Orthopedics | Surgery | Conservative Orthopedics | Medicine/Public Health, general | Life Sciences & Biomedicine | Science & Technology | Community-Acquired Infections - diagnosis | Community-Acquired Infections - therapy | Community-Acquired Infections - transmission | Hospital Costs | Cross Infection - economics | Humans | Orthopedic Procedures - adverse effects | Infection Control - methods | Cost Savings | Cross Infection - transmission | Staphylococcal Infections - microbiology | Surgical Wound Infection - transmission | Cross Infection - prevention & control | Mass Screening - economics | Community-Acquired Infections - economics | Surgical Wound Infection - economics | Anti-Infective Agents - therapeutic use | Treatment Outcome | Staphylococcal Infections - therapy | Staphylococcal Infections - transmission | Surgical Wound Infection - prevention & control | Staphylococcal Infections - diagnosis | Staphylococcal Infections - economics | Cost-Benefit Analysis | Cross Infection - microbiology | Surgical Wound Infection - diagnosis | Cross Infection - diagnosis | Orthopedic Procedures - economics | Staphylococcal Infections - prevention & control | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Program Evaluation | Surgical Wound Infection - microbiology | Community-Acquired Infections - microbiology | Infection Control - economics | Online health care information services | Orthopedic surgery | Health aspects | Analysis | Staphylococcal infections | Staphylococcus aureus | Index Medicus | Abridged Index Medicus | Survey
Journal Article
Details
Digital rights
Loading RightsClinical infectious diseases, ISSN 1058-4838, 9/2015, Volume 61, Issue suppl 2, pp. S69 - S78
telavancin | necrotizing infections | skin infections | cellulitis | soft-tissue infections | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Skin Diseases, Bacterial - microbiology | Humans | Skin Diseases, Bacterial - drug therapy | Oxazolidinones - therapeutic use | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Skin Diseases, Bacterial - epidemiology | Gram-Positive Bacterial Infections - microbiology | Soft Tissue Infections - drug therapy | Staphylococcal Infections - microbiology | Daptomycin - therapeutic use | Staphylococcal Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Gram-Negative Bacterial Infections - drug therapy | Clinical Trials as Topic | Soft Tissue Infections - epidemiology | Gram-Positive Bacterial Infections - epidemiology | Daptomycin - pharmacology | Soft Tissue Infections - microbiology | Staphylococcal Infections - epidemiology | Oxazolidinones - pharmacology | Gram-Negative Bacterial Infections - epidemiology | Anti-Bacterial Agents - pharmacology | North America - epidemiology | Aminoglycosides - pharmacology | Gram-Positive Bacterial Infections - drug therapy | Aminoglycosides - therapeutic use | Staphylococcus infections | Antimicrobial agents | Mortality | Medical treatment | Morbidity | Streptococcus infections | Index Medicus
Journal Article
Details
Digital rights
Loading Rights